3D-printed drugs are moving off the Science Fiction shelf and into real life with the FDA approval of Spritam, an anti-seizure medication from Aprecia Pharmaceuticals. Will this development set a new precedent for drug manufacturing? Dr. Matt Birnholz reports.
Meds Get a Makeover: FDA Approves First 3D-Printed Drug

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
3D-printed drugs are moving off the Science Fiction shelf and into real life with the FDA approval of Spritam, an anti-seizure medication from Aprecia Pharmaceuticals. Will this development set a new precedent for drug manufacturing? Dr. Matt Birnholz reports.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Engaging Patients and Caregivers About Digital Therapeutics
Beyond Plaques: Current Concepts in Alzheimer’s Pathophysiology
FCS and SHTG: Are We Meeting the Need?
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
Optimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
Level Up Your Skills: Tailoring Management of HF
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?